Review
doi: 10.1006/jmbi.2000.4265.
Stability engineering of antibody single-chain Fv fragments
Affiliations
- PMID: 11162109
- DOI: 10.1006/jmbi.2000.4265
Item in Clipboard
Review
Stability engineering of antibody single-chain Fv fragments
J Mol Biol.
.
Abstract
The application of single-chain Fv fragments (scFv) in medicine and biotechnology places great demands on their stability. Only recently has attention been given to the production of highly stable scFvs, and in a number of examples it was found that such fragments indeed perform better during practical applications. The structural parameters influencing scFv stability are now beginning to be elucidated. This review summarizes progress in rational and evolutionary engineering methods, the structural implications of these results, as well as some examples where stability engineering has been successfully applied.
Similar articles
-
A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.J Mol Biol. 2001 Jul 13;310(3):603-15. doi: 10.1006/jmbi.2001.4756. J Mol Biol. 2001. PMID: 11439027
-
Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.J Mol Biol. 2001 Jul 13;310(3):591-601. doi: 10.1006/jmbi.2001.4703. J Mol Biol. 2001. PMID: 11439026
-
Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.Mol Immunol. 2008 May;45(9):2474-85. doi: 10.1016/j.molimm.2008.01.016. Epub 2008 Mar 3. Mol Immunol. 2008. PMID: 18313757
-
Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.Nat Biotechnol. 1996 Oct;14(10):1239-45. doi: 10.1038/nbt1096-1239. Nat Biotechnol. 1996. PMID: 9631086 Review.
-
Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering.Methods. 2004 Oct;34(2):184-99. doi: 10.1016/j.ymeth.2004.04.007. Methods. 2004. PMID: 15312672 Review.
Cited by
-
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding.MAbs. 2016 Oct;8(7):1319-1335. doi: 10.1080/19420862.2016.1210747. Epub 2016 Aug 17. MAbs. 2016. PMID: 27532598 Free PMC article.
-
Engineering tandem single-chain Fv as cell surface reporters with enhanced properties of fluorescence detection.Protein Eng Des Sel. 2015 Oct;28(10):327-37. doi: 10.1093/protein/gzv016. Epub 2015 Apr 5. Protein Eng Des Sel. 2015. PMID: 25843939 Free PMC article.
-
Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.BMC Biotechnol. 2011 Nov 30;11:117. doi: 10.1186/1472-6750-11-117. BMC Biotechnol. 2011. PMID: 22129156 Free PMC article.
-
Directed evolution methods for overcoming trade-offs between protein activity and stability.AIChE J. 2020 Mar;66(3):e16814. doi: 10.1002/aic.16814. Epub 2019 Oct 9. AIChE J. 2020. PMID: 32719568 Free PMC article.
-
Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors.Front Immunol. 2022 Nov 2;13:1005800. doi: 10.3389/fimmu.2022.1005800. eCollection 2022. Front Immunol. 2022. PMID: 36405759 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
